Abstract
Most stem cell transplants are performed to treat neoplasms. Yet many patients survive the transplant but die from cancer recurrence post-transplant. The incorporation of post-transplant immunotherapy offers the potential for enhanced antitumor efficacy.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Bone Marrow Transplantation / adverse effects
-
Bone Marrow Transplantation / methods*
-
Child
-
Child, Preschool
-
Female
-
Graft vs Tumor Effect / immunology*
-
Hematologic Neoplasms / mortality
-
Hematologic Neoplasms / therapy*
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Immunotherapy*
-
Killer Cells, Natural / immunology*
-
Lymphocyte Activation
-
Male
-
Neoplasm Recurrence, Local / prevention & control*
-
Prognosis
-
Survival Rate
-
Transplantation, Autologous
-
Transplantation, Homologous
-
Treatment Outcome